AML-488: A Phase 1 Study of Gemtuzumab Ozogamicin Added to Cytarabine, Daunorubicin, and Midostaurin Induction in Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia
Year: 2025
Type: conference-abstract
Authors: Jayanshu Jain, Kelly Pugh, Shivani Handa, Kaitlyn Dvorak-Kornaus, Qiuhong Zhao, Roland Walter, Rachel Cook, Jennifer Saultz, Ronan Swords, Junyang Li, George Laszlo, Nicole Grieselhuber, Alice Mims, Karilyn Larkin, Kieran Sahasrabudhe, James Blachly, Gregory Behbehani, Ann-Kathrin Eisfeld, Meixiao Long, Andrew Srisuwananukorn, Kristin Koenig, Uma Borate
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413783194